[1]
F. Pirozzi Farina and A. Pischedda, “Comments concerning the real risk of sexual adverse events secondary to the use of 5-ARIs”, Arch Ital Urol Androl, vol. 87, no. 4, pp. 312–316, Jan. 2016.